Cargando…
Does Trastuzumab Offer Good Value for Money for Breast Cancer Patients with Metastasis in Indonesia?
OBJECTIVE: Breast cancer is the most common cancer in Indonesia, with Indonesia’s breast cancer mortality rate being the highest among Southeast Asian countries. This study aims to evaluate the cost-effectiveness and budget impacts of adding trastuzumab to chemotherapy versus chemotherapy alone for...
Autores principales: | Kristin, Erna, Endarti, Dwi, Khoe, Levina Chandra, Pratiwi, Woro Rukmi, Pinzon, Rizaldy Taslim, Febrinasari, Ratih Puspita, Yasmina, Alfi, Nugrahaningsih, Dwi Aris Agung, Taroeno-Hariadi, Kartika Widayati, Karsono, Ramadhan, Sudarsa, I Wayan, Prenggono, Muhammad Darwin, Herlinawaty, Eva, Komaryani, Kalsum, Hidayat, Budi, Nadjib, Mardiati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727367/ https://www.ncbi.nlm.nih.gov/pubmed/35901352 http://dx.doi.org/10.31557/APJCP.2022.23.7.2441 |
Ejemplares similares
-
Economic Evaluation of Adding Bevacizumab to Chemotherapy for Metastatic Colorectal Cancer (mCRC) Patients in Indonesia
por: Kristin, Erna, et al.
Publicado: (2021) -
The 5-Year Disease-Free Survival of Third Generation Aromatase Inhibitor for Postmenopausal Women with HR-Positive HER2-Negative Non-Metastatic Breast Cancer
por: Etikasari, Ria, et al.
Publicado: (2023) -
Health- Related Quality of Life for Multiple Myeloma Patients with Bone Metastases in Indonesia: A Cross-Sectional Study
por: Sayuti, Nutrisia Aquariushinta, et al.
Publicado: (2019) -
Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia
por: Afiatin,, et al.
Publicado: (2017) -
Evaluation of crystal violet decolorization assay and resazurin microplate assay for antimycobacterial screening
por: Rakhmawatie, Maya Dian, et al.
Publicado: (2019)